593 related articles for article (PubMed ID: 32642851)
1. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg S; Al-Daghri N; Aubertin-Leheudre M; Brandi ML; Cano A; Collins P; Cooper C; Genazzani AR; Hillard T; Kanis JA; Kaufman JM; Lambrinoudaki I; Laslop A; McCloskey E; Palacios S; Prieto-Alhambra D; Reginster JY; Rizzoli R; Rosano G; Trémollieres F; Harvey NC
Osteoporos Int; 2020 Dec; 31(12):2271-2286. PubMed ID: 32642851
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy for the management of osteoporosis.
Gosset A; Pouillès JM; Trémollieres F
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101551. PubMed ID: 34119418
[TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
4. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis.
Na Z; Wei W; Xu Y; Li D; Yin B; Gu W
Open Life Sci; 2023; 18(1):20220759. PubMed ID: 38152576
[TBL] [Abstract][Full Text] [Related]
5. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
6. Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Anagnostis P; Paschou SA; Katsiki N; Krikidis D; Lambrinoudaki I; Goulis DG
Curr Vasc Pharmacol; 2019; 17(6):564-572. PubMed ID: 29984659
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy for postmenopausal osteoporosis management.
Jiang X; Kagan R
Climacteric; 2022 Feb; 25(1):50-55. PubMed ID: 34402365
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.
Ran SY; Yu Q; Chen Y; Lin SQ
Climacteric; 2017 Aug; 20(4):391-396. PubMed ID: 28523945
[TBL] [Abstract][Full Text] [Related]
9. Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis.
Rozenberg S; Vandromme J; Revercez P; Valcarenghi M; Joris A
Cancer J; 2022 May-Jun 01; 28(3):204-207. PubMed ID: 35594468
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and breast cancer risk.
Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
[TBL] [Abstract][Full Text] [Related]
11. Menopausal Hormone Therapy: a Comprehensive Review.
Lundberg G; Wu P; Wenger N
Curr Atheroscler Rep; 2020 Jun; 22(8):33. PubMed ID: 32556827
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and bones after menopause: a reappraisal of data and future perspectives.
Anagnostis P; Bosdou JK; Vaitsi K; Goulis DG; Lambrinoudaki I
Hormones (Athens); 2021 Mar; 20(1):13-21. PubMed ID: 32519298
[TBL] [Abstract][Full Text] [Related]
13. The role of menopausal hormone therapy in the management of osteoporosis.
de Villiers TJ
Climacteric; 2015; 18 Suppl 2():19-21. PubMed ID: 26474003
[TBL] [Abstract][Full Text] [Related]
14. A review of menopausal hormone therapy: recalibrating the balance of benefit and risk.
Rajan S; Kreatsoulas C
Pol Arch Intern Med; 2019 Apr; 129(4):276-280. PubMed ID: 30608056
[TBL] [Abstract][Full Text] [Related]
15. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
16. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
[TBL] [Abstract][Full Text] [Related]
17. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
Gu Y; Han F; Xue M; Wang M; Huang Y
BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
[TBL] [Abstract][Full Text] [Related]
18. What the Women's Health Initiative has taught us about menopausal hormone therapy.
Chester RC; Kling JM; Manson JE
Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
[TBL] [Abstract][Full Text] [Related]
19. Treating menopause - MHT and beyond.
Davis SR; Baber RJ
Nat Rev Endocrinol; 2022 Aug; 18(8):490-502. PubMed ID: 35624141
[TBL] [Abstract][Full Text] [Related]
20. The role of menopausal hormone therapy in the prevention and treatment of low bone density in perimenopausal and postmenopausal women.
Shah N; Ariel D
Curr Opin Obstet Gynecol; 2023 Apr; 35(2):141-149. PubMed ID: 36912327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
